CA2329859A1 - Nanometer particles containing a reactive monolayer - Google Patents

Nanometer particles containing a reactive monolayer Download PDF

Info

Publication number
CA2329859A1
CA2329859A1 CA002329859A CA2329859A CA2329859A1 CA 2329859 A1 CA2329859 A1 CA 2329859A1 CA 002329859 A CA002329859 A CA 002329859A CA 2329859 A CA2329859 A CA 2329859A CA 2329859 A1 CA2329859 A1 CA 2329859A1
Authority
CA
Canada
Prior art keywords
group
monolayer
mixtures
core
particle according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002329859A
Other languages
French (fr)
Inventor
Allen C. Templeton
Michael J. Hostetler
Jeremy J. Pietron
Royce W. Murray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2329859A1 publication Critical patent/CA2329859A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346Nanoparticles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004Preparation of sols
    • B01J13/0043Preparation of sols containing elemental metal
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553Metal or metal coated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587Nanoparticles

Abstract

A nanometer-sized particle comprises a core comprising at least one metal or metal alloy; and a monolayer chemically bonded to the core. The monolayer contains at least one reactive substituent which is coupled to a functional material such that the monolayer is chemically modified. A method of making a functionalized nanometer-sized particle comprises providing a nanometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto the core wherein the monolayer includes at least one reactive substituent; and coupling the nanometer-sized particle with a functional material such that the monolayer is chemically modified.

Description

NANOMETER SIZED PARTICLES CONTAINING A REACTIVE MONOLAYER
ADSORBED THEREON AND METHODS OF MAKING THE SAME
Field of the Invention The invention generally relates to manometer-sized particles which have been chemically modified and methods of making the same.
Background of the Invention Technology involving the synthesis of manometer-sized particles ("nanotechnology") has gained widespread attention recently. Broadly speaking, nanotechnology relates to the art and science of building molecular materials so that they are capable of functioning as macro-scale structures and/or exhibiting physical and chemical properties which are intermediate between molecular and bulk materials. Applications involving nanotechnology are potentially far reaching. Areas of possible interest relate to, for example, catalysis, molecular electronics, biotechnology, composite materials, solar energy conversion, and 3o the like. Investigative efforts regarding nanotechnology have focused largely on understanding the physical behavior and structure of manometer-sized materials.
Reiss, H., Proceedings of the Welch Foundation 39~" Conference on Chemical Research: Nanophase Chemistry (1995) 49-fib discusses thermodynamic behavior associated with nanophase technology. Berry, R.S., Proceedings of the Welch Foundation 39t" Conference on Chemical Research: Nanophase Chemistry, (1995), 71-81 focuses on the surface behavior of nanometer sized particles. Quate, C.F., Proceedings of the Welch Foundation 40r" Conference on Chemical Research: Nanophase Chemistry (1996) 87-95, discusses the use of a scanning probe lithography in fabricating nanostructures. Schon, G., et al., 4o Colloid Polym. Sci. 273 (1995) 202-218, discusses uses of nanometer-sized particles relevant to the microelectronics industry.
Nanometer-sized gold particles can be chemically attached to metal surfaces, such as electrodes. The purpose of such experiments is to allow the researcher to add functionality onto the immobilized particles in order to add 45 value to the metal surface. For example, Freeman, R.G., et al., Science 267 (1995) 1629-1632, propose linking gold and silver colloidal particles to a silanized surface. Doron, A., et al., Langmuir 11 (1995) 1313-1317, proposes linking gold colloid particles to an indium tin oxide surface, followed by further functionalizing the exposed edge of the bound colloid particles with electroactive 5o functional groups. The aforementioned techniques may be limited to surface immobilized particles which makes characterization of the end-functionalized material difficult and uncertain. Furthermore, there is a potential general constraint in that the size of the particle attached to the surface is significantly less able to participate in the functionalization reactions. In essence, the 55 aforementioned work may be useful only as a means to add value to a large (millimeter or micrometer scale) surface.
Metal sots are small particles which are insoluble, and thus suspended, in the liquid in which they are dispersed. Numerous recent studies have investigated methods for adding to the complexity of metal sols. For example, so Mirkin, C.A., et al., Nature 382 (1996) 607-609, proposes attaching oligonucleotides to gold sots in order to promote aggregation of said sols upon addition of an appropriate complementary oligonucleotide to the sol solution.
U.S. Patent No. 4,859,612, to Cole et al. proposes that antibody coated metal sots can interact with an appropriately coated solid phase particle as a means for 65 an immunoassay procedure. U.S. Patent Nos. 5,294,369 and 5,384,073 to Shigekawa et al. propose that gold sots can be mixed in an alcohol solution containing alkanethiol derivatives. Upon isolation of the particles, antigens, antibodies, and ligands can be further linked to the gold particle via a reaction in an aqueous buffer. In all of the aforementioned examples, the proposed 7o methodology may be limited to metal sols, reactions in heterogeneous media, and a specific subset of functionalized materials. The constraints of the aforementioned methods potentially make analysis of the monolayer difficult and unreliable.
In addition to the above, recent efforts have focused on producing 75 manometer-sized particles having other materials chemically or physically attached thereto. For example, Brust, M., et al., J. Chem. Soc, Chem. Commun.
(1994) 801-802, proposes manometer-sized gold cores which are stabilized by chemisorbed layers of dodecanethiolate. The resulting rYiaterial is soluble in non-polar organic solvents and can be repeatedly isolated and reused. Terrill, R.
8o H., et al., J. Am. Chem. Soc., 117:50 (1995) 12537-12548, proposes nanometer-sized gold cores which are stabilized by chemisorbed layers of octane- or hexadecanethiolate. These monolayer-protected gold clusters were found to be highly stable as determined by differential scanning calorimetry techniques.
Hostetler, M.J., et al., Langmuir, 12 (1996) 3604-3612, relates to the evaluation 85 of the physical structure of alkanethiolates of various chain lengths adsorbed onto manometer-sized gold cores. Alkanethiolates with shorter chain lengths were determined to be relatively disordered while materials with longer chain lengths were found to be in the trams zig-zag conformation. The previous three descriptions of the art represent manometer-sized gold cores covered with 9o simple, non-derivatized alkanethiols, a circumstance that severely limits their applicability.
Hostetler, M.J., et. al., J. Am. Chem. Soc., 118 (199fi) 4212-4213 proposes manometer-sized gold cores stabilized by mixed monolayers of unsubstituted and co-substituted (cyano, bromo, vinyl, ferrocenyl) alkanethiolates.
95 A potential limitation of this and other methods are that they typically rely on WO 99/61911 PCT/US99/0?823 either commercially available or easily-prepared t~substituted alkanethiols.
Another deficiency in these methods is that formation of the rv-substituent often does not occur on the protected gold cores, causing the need for extensive purification steps that can only produce a narrow range of compounds.
Notwithstanding the above, there is a need in the art for manometer-sized materials which exhibit specific chemical and physical properties. More particularly, there is a need for such materials which can be tailored for utilization in a number of defined end use applications. It would be particularly desirable if the manometer-sized particles exhibited flexible chemical behavior as well as X05 multiplicity with respect to reactivity. It would also be particularly worthwhile if the reverse engineering needed to design the synthesis of an envisioned multi-functionalized manometer-sized particle would be straightforward and understandable. It would be notably beneficial if the reactions forming the particles were homogeneous, flexible, easy to learn, and reliable. This would be 11o especially advantageous in analytical applications involving the solubilization of the manometer-sized particles in aqueous or organic solvents.
Summary of the Invention It is therefore an object of the present invention to provide nanometer-~~5 sized particles which may be chemically tailored to be desirable in a variety of applications.
These and other objects and features are provided by the present invention. In one aspect, the invention relates to a functionalized nanometer-sized particle comprising a core which comprises at least one metal or metal ~2o alloy; and a monolayer chemically bonded to the core. The monolayer is formed during the formation of the core and can be modified at any time following formation of the core. Advantageously, the monolayer contains at least one reactive substituent thereon which is coupled to a functional material such that the monolayer becomes chemically modified. The reactive substituent may be X25 selected from a number of groups such as, for example, SH, OH, NH2, NH, WO 99/61911 PC'TNS99/07823 C02H, S030H, P02(OH)2, BO(OH)2, or mixtures thereof. By virtue of the manometer-sized particle structure, a number of functional materials may be employed such as catalysts, biomaterials, and materials which are chemically, electrochemically, or photochemically active. Thus, the particles may be readily ~3o used in a number of applications.
In another aspect, the invention relates to a method of making a functionalized manometer-sized particle. The method comprises providing a manometer-sized particle comprising: (1) a core which comprises at least one metal or metal alloy and (2) a monolayer chemically bonded to the core, the X35 monolayer including at least one reactive substituent. The manometer-sized particle is then coupled with a functional material such that the monolayer becomes chemically modifed. Importantly, this method allows for the particle to be modified based on a small subset of reactive substituents, all of which can be readily synthesized or purchased commercially. Adding greater value to said manometer-sized particle can then be accomplished using a variety of functional materials.
Brief Description of the Drawings FIG. 1 is a representation of a multi-step synthesis of a tripeptide-functionalized monolayer-protected manometer-sized gold core.
FIG. 2a is a graph illustrating the electrochemical characterization of a 10H-(phenothiazine-10)propionic acid-functionalized monolayer-protected manometer-sized gold core. Specifically, the figure illustrates the cyclic ~so voltammetry of 0.8 mM 10H (phenothiazine-10)propionic acid (--) in 2:1 toluene/acetonitrile (v/v) at 100mV/s; and FIG. 2b is a graph illustrating the thin layer coulometry charge Q vs. cell length (L) (rz=0.98; slope=11.47 X 10-3 C/cm).

X55 Detailed Description of the Preferred Embodiments The present invention now will be described more fully hereinafter with reference to the accompanying specification, examples, and drawings, in which preferred embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art.
In one aspect, the invention relates to a functionalized nanometer-sized particle. The functionalized nanometer-sized particle comprises a core 165 comprising at least one metal or metal alloy. For the purposes of the invention, the core preferably has a diameter ranging from about 1 nm to about 999 nm, more preferably from about 1 nm to about 100 nm; even more preferably from about 1 nm to about 20 nm; and most preferably from about 1 nm to about 7 nm.
A monolayer is chemisorbed or chemically bonded to the core. The monolayer contains at least one reactive substituent as described further herein.
Advantageously, the reactive substituent(s) on the monolayer is/are coupled to a functional material so as to chemically modify the monolayer.
A number of metals and metal alloys may be used in the core. Preferably, the metal or metal alloy is selected from the group consisting of 175 a semiconducting material, a metal oxide material, a Group VIIIA element, a Group IB element, a Group IIB element, alloys thereof, and mixtures thereof.
More preferably, the metal or metal alloy is selected from the group consisting of a Group VIIIA element, a Group IB element, alloys thereof, and mixtures thereof.
Examples of elements which may be used include, but are not limited to, gold, o silver, copper, palladium, platinum, nickel, and alloys thereof. Examples of semiconducting materials include, but are not limited to, cadmium sulfide, indium phosphide, and other Group III-V materials. Example of oxide materials include, but are not limited to, titanium oxide (titania), aluminum oxide (alumina), tin oxide, and iron oxide. The shape of the core is not restricted to any particular 185 geometry, thus, for example, rods, spheres, cuboctahedra, and truncated octahedra, will all satisfy the conditions stated herein.
For the purposes of the invention, the term "monolayer" may be defined as a layer preferably having a thickness ranging from about 0.4 nm to about nm, and more preferably 1.0 to 20 nm. Although not wishing to be bound by any one embodiment, the monolayer is typically formed during the formation of the core, and the monolayer can be modified at any point following formation of the core. The monolayer which is adsorbed or chemically bonded to the core may comprise a number of materials. Examples of these materials include, but are not limited to, organic compounds (e.g., alkanethiols, arylthiols, vinylthiols, 195 and their derivatives); inorganic compounds (e.g.,alkyl borates, alkyl phosphonates, alkyl silicates), organometallic compounds {e.g., ferrocenethiol);
biochemical compounds (e.g., cysteine, albumin, coenzyme A), and mixtures thereof.
In referring to the molecular structure of the monolayer, substituents which 20o may be present on the monolayer include, for example, branched molecules (e.g., branched alkyl chains, multiply substituted aryl groups, multiply substituted cyclic aliphatic compounds), hyperbranched molecules (e.g., dendritic molecules); and mixtures thereof. As an example of a non-branched substituent, the monolayer may comprise an alkanethiol or an alkanethiol derivative.
205 Exemplary alkanethiols include those having between 2 and 23 carbon atoms.
As alluded to herein, the monolayer contains at least one reactive substituent. For the purposes of the invention, the term "reactive substituent"
refers to those substituents which are chemically active so that, upon reaction with a functional material, part of the reactive substituent remains with the 21o product, serving as a linking or coupling group between the original part of the molecule and the new portion of the molecule. Examples of reactive substituents include, but are not limited to, SH, OH, NH2, NH, C02H, S030H, P02(OH)2, BO(OH)2, and mixtures thereof. More preferably, OH, NH, C02H, NH2, and mixtures thereof are employed. Examples of compounds which may be present 215 on the reactive substituent are described by the general formula:
R~(EH)x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof; E is selected from the group consisting of S, O, NH, COO, 22o S030H, P02(OH)2, BO(OH)2, C02, NH2, and mixtures thereof; n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, CO2, NH2, and mixtures thereof. The chemically modified monolayer may also include partially reactive and nonreactive compounds or materials.
225 Compounds or materials being "partially reactive" refer to those containing groups which do not participate in coupling but instead are capable of undergoing substitution reactions, elimination reactions, oxidative and reductive reactions, and the like. "Nonreactive" compounds or materials refer to those which do not undergo the above reactions. Reactive, partially reactive, and 23o nonreactive compounds or materials may be used in any ratio so long as at least one reactive compound or material is present on the monolayer.
The monolayer is preferably chemically bonded to the core by various types of bonds. Examples of these bonds include, but are not (united to, core-element-sulfur bonds, core-element-oxygen-bonds, core-element-boron, core-235 element-phosphorus, and core-element-nitrogen-bonds. Combinations of these types of bonds may also be used. In the most preferred embodiment the monolayer is chemically bonded to the core by various core-element-sulfur bonds. In the aforementioned embodiments, core-element refers to any elenent of which the core is composed.
24o In accordance with the invention, the monolayer is coupled to a functional material such that the monolayer is chemically modified. The term "coupled"
may be interpreted to mean that the monolayer and the functional material are linked via formation of a new chemical bond. Examples, include, but are not limited to amide, thioester, and ester-forming reactions known in the art.
245 Examples of functionalities which may be present on the functional materials include, but are not limited to, SH, OH, NH2, NH, C02H, S030H, P02(OH)2, BO(OH)2, and mixtures thereof. Examples of reactive substituents include, but are not limited to, SH, OH, NH2, NH, C02H, S030H, P02(OH)2, BO(OH)2, and mixtures thereof. More preferably, OH; NH, C02H, NH2, and mixtures thereof 25o are employed. The functional material may also comprise at least one compound having the general formula:
Ft~(EH)X
wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, 255 and mixtures thereof; E is selected from the group consisting of S, O, NH, COO, S030H, POZ(OH)Z, BO(OH)2, COZ, NHZ, and mixtures thereof; n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C02, NH2, and mixtures thereof. It should be emphasized that the 2so functional material may be present in the form of a number of structures which possesses functionality in the manner described herein. For example, the functional material may be a catalyst, a biomaterial, a material which is electrochemically active, or combinations thereof. The functional material may also be one which has a low-lying excited state which is capable of undergoing 2s5 fluorescence or electron-transfer when excited. The functional material may also be selected such that the manometer-sized particle is soluble in a solvent.
The term "soluble" may be defined to mean the particles being dispersed or dissolved in the solvent. Examples of suitable solvents include aqueous or organic solvents.
27o In another aspect, the invention relates to a method of making a functionalized manometer-sized particle. The method comprises providing a manometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto the core. The monolayer includes at least one reactive substituent. The manometer-sized particle is then 275 coupled with a functional material such that the monolayer is chemically modified.
A number of functional materials may be used in the above method.
Examples of these materials include, but are not limited to, spin labels (e.g., 4-amino-TEMPO), metal ligands (e.g., 4-(aminomethyl)-pyridine), amino acids 280 (e.g., glutamic acid di-f butyl ester), chromophores and fluorophores (e.g., 1-aminopyrene and 2-naphthaleneethanol), ionophores (e.g., 2-(aminomethyl)-15-crown-5), molecules susceptible to functional group conversion {e.g., benzyl amine), electroactive molecules (e.g., ferrocene methanol, 10H-(phenothiazine-10) propionic acid, anthraquinone-2-carboxylic acid), sugars (e.g., a-D-glucose), 285 nucleotides {e.g., uridine), and mixtures thereof.
The coupling step is preferably carried out in the presence of a reagent which may be, for example, a phophonium reagent, a facilitating reagent, as well as mixtures thereof. Preferably, the facilitating reagent may be selected from a base, a catalyst, and mixtures thereof. Preferred bases include various pyridine 290 derivatives. Other examples of components which may be employed during the coupling step include, but are not limited to, BOP (benzotriazol-1-yloxytris{dimethylamino)phosphonium hexafluorophosphate); HOBt (1-hydroxybenzotriazole); NMM (4-methylmorpholine); DMAP (4-dimethylaminopyridine); and mixtures thereof.
2s5 In another aspect, the invention relates to a method of analyzing a manometer-sized particle. The method comprises subjecting a manometer-sized particle as defined herein to an analytical technique such that the composition of the functional materials of the monolayer on the particle are determined. A
number of analytical techniques may be employed in this method. Examples of 30o such techniques include, but are not limited to, NMR spectroscopy, electrochemical techniques, fluorescent emission spectroscopies, and infrared spectroscopies.

Examples 305 The examples which follow are set forth to illustrate the invention, and are not meant as a limitation thereon. Although the following examples explicitly employ only monolayer-protected manometer-sized gold cores, other monolayer-protected manometer-sized cores (comprising at least one metal or metal alloy which is selected from the group consisting of a semiconducting material, an 3~0 oxide material, a Group VIIIA element, a Group IB element, a Group IIB
element, alloys thereof, and mixtures thereof) have reactivity and stability that allow their use with the reaction conditions set forth below; thus, one skilled in the art could reasonably expect that the examples set forth below would be applicable to all embodiments set forth in the claims of this patent.
3~5 In the examples, 10H-(phenothiazine-10)propionic acid was synthesized according procedures set forth in Peek, B.M. et al., Int. J. Peptide Protein Res.
38 (1991) 114. 11-mercapto-undecanoic acid and 11-mercapto-undecanol were either synthesized according to a procedure described in Bain, C.D. et al., J.
Am.
Chem. Soc. 111 (1989) 321; or purchased from the Aldrich Chemical Company 320 of Milwaukee, Wisconsin (95% and 97% purity, respectively).
Tetrahydrofuran (less than 16 ppm water content) was used for all coupling reactions. The synthesis of manometer-sized gold cores which are stabilized by chemisorbed layers of dodecanethiolate was accomplished in accordance with a procedure described Hostetler, M.J., et al., Langmuir 14 (1998) 17-30 and addition of w-Z-325 alkanethiol (with Z being COOH or OH) onto the manometer-sized gold cores was accomplished as described in Hostetler, et al., J. Am. Chem. Soc. 118 (1996} 4212-4213. All other reagents were used as received. Nomenclature for the manometer-sized gold cores protected by a complex monolayer may be defined as CX:CYZ (a:b) wherein X specifies the length of the alkanethiol chain, 33o Y specifies the chain length of the place exchanged w-Z-alkanethiol (with Z being COOH or OH) and (a:b) specifies the mole ratio of X and Y chains in the monolayer on the manometer-sized gold core as determined from the methyI/CH2R'H NMR spectral ratio in solutions of manometer-sized gold cores protected by complex monolayers that have been treated with 12 in order to 335 remove the monolayer from the nanometer-sized gold core as taught in Templeton, A.C., et al., J. Am. Chem. Soc., 120 (1998) 1906-1911. Percent conversion data was determined using the aforementioned methodology.
With respect to the spectroscopy data,'H NMR spectra (in Ceps, CD2CI2, or CDC13) were obtained using a Bruker AMX 200 MHz spectrometer sold by 34o Bruker Instruments, Inc. of Billerica, Massachusetts. A line broadening factor of 1 Hz was used to improve the S/N of the NMR resonances belonging to the monolayer on the nanometer-sized gold core. Infrared absorbence spectra of clusters as thin films were acquired using a Biorad 6000 FTIR spectrometer sold by Bio-Rad Laboratories, Inc. of Cambridge, Massachusetts. Reported IR bands 345 are those that are unique to each functionalized monolayer-protected nanometer-sized gold core (an infrared spectra of a nanometer-sized gold core which is stabilized by chemisorbed layers of dodecanethiolate was used for background subtraction).
The examples set forth below employ the following abbreviations for the 35o sake of brevity: THF (tetrahydrofuran); DMF (dimethylformamide); MPC
(monolayer-protected nanometer-sized gold core); BOP (benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate); HOBt (1-hydroxybenzotriazole); NMM (4-methylmorpholine); DMAP (4-dimethylaminopyridine); 4-amino-TEMPO (4-amino-2,2,6,6-355 tetramethylpiperidinyloxy, free radical); IR (infrared); NMR (nuclear magnetic resonance); EPR (electron paramagnetic resonance); ml (milliliter); mg (milligram); ppm (parts per million); cm'' (wavenumbers); d+ (symmetric methylene stretching vibration); d' (antisymmetric methylene stretching vibration);
br (broad. All reactions were performed within the temperature range 15 to 35 °
360 C, although one skilled in the art would reasonably assume that the reactions would also be functional in the temperature range -80 to 100 °C.

ExamJ~les 1-6 Coupling of Amines to C12:C11COOH (a:b) 3s5 Various coupling reactions were performed according to a procedure set forth in McCafferty et al., Tetrahedron 51 (1995) 1993. In these examples, ca.
100 mg of acid MPC (C12:C11COOH MPC (4:1)) was treated with five equivalents {relative to moles of MPC acid groups) of BOP (60 mg), HOBt (18 mg), NMM (14 uL), and DMAP (16 mg) in low water THF {concentration of 2 mg 37o cluster/mL). Following a brief activation period (10 minutes), five equivalents of a specified amine was added to the reaction mixture and the solution was stirred at room temperature for 15 hours. The solvent was then removed under vacuum and the reacted MPC was collected on a frit where unreacted materials were removed by washing with 500 mL of acetonitrile followed by sonication/decanting 375 with 50 mL acetonitrile (3X).
Example 1 4-amino-TEMPO (spin label) The above procedure was carried out using 4-amino-TEMPO as the 38o amine. The following data were obtained: IR: 2851 (d+), 2922 (d-), 1641, crri'. The EPR spectrum is shown in Figure 2. The percent conversion to number coupled ratio was determined to be 95/13.
Example 2 385 4-(aminomethyl)-pyridine (metal ligand) The above procedure was carried out using 4-(aminomethyl)-pyridine as the amine. The following data were obtained; NMR (in CDZC12): 8(ppm) = 0.89 (br, 15.6 H), 1.28 (br, H), 1.74 (br, H), 2.21 (br, 3.1 H), 4.32 (br, 1.9 H), 7.12 (br, 2.3 H), 8.43 (br, 2 H). IR: 2850 (d+), 2920 (d-), 1653, 1602, 1539 cm''. The 3so percent conversion to number coupled ratio was determined to be 95/9.5.

Example 3 glutamic acid di-t-butyl ester (amino acid) The above procedure was carried out using glutamic acid di-t butyl ester 395 as the amine. The following data were obtained: NMR (in CgDB): 8 (ppm) =
1.02 (br, 27 H), 1.4 (br, 218 H), 2.3 (br, 28 H), 4.8 (br, 2 H). IR: 2850 (d~), 2920 (d-), 1734, 1680, 1650, 1536, 1392, 1367, 1155 cm'. The percent conversion to number coupled ratio was determined to be 9014.
400 Example 4 1-aminopyrene (chromophore; fluorophore) The above procedure was carried out using 1-aminopyrene as the amine.
The following data were obtained: NMR (in CD2CI2): 8 (ppm) = 0.85 (br, 3 H), 1.3 (br, 15 H), 1.85 (br, 1.9 H), 3.35 (br, 0.33 H), 3.55 (br, 0.32 H), 7.15 (br, 0.02 H), 405 7.45 (br, 0.04 H), 7.7 (br, 0.06 H), 8.0 (br, 0.18 H). IR: 2851 (d+), 2921 (d-), 1735, 1700, 1655, 1601, 1558, 1517 cm-'. The percent conversion to number coupled ratio was determined to be 95/7.
Example 5 41o 2-(aminomethyl)-15-crown-5 (ionophore) The above procedure was carried out using 2-(aminomethyl)-15-crown-5 as the amine. The following data were obtained: NMR (in C6Dg): 8 (ppm) = 0.75 (br, 0.8 H), 1.0 (br, 3 H), 1.45 (br, 18 H), 2.25 (br, 2 H), 3.6 (br, 3.8 H).
IR: 2949 (d+), 2922 (d'), 1734, 1650, 1543, 1122 cm'. The percent conversion to number 415 coupled ratio was determined to be 80/8.
Example 6 benzyl amine (group conversion) 42o The above procedure was carried out using benzyl amine as the amine.
The following data were obtained: NMR (in CD2C12): 8 (ppm) = 0.90 (br, 31 H), 1.3 (br, 141 H), 2.2 (br, 4 H), 4.4 (br, 3 H), 7.3 (br, 5 H). IR: 2850 (d+), 2920 (d'), 1734, 1646, 1547 cm'). The percent conversion to number coupled ratio was determined to be 95/7.

Examples 7-10 Coupling of alcohols to C12:C11COOH (a:b) In reactions set forth in these examples, ca. 100 mg of the acid MPC
(C12: C11COOH (4:1)) was treated with five equivalents (relative to the moles of 43o MPC acid groups) of BOP (60 mg), HOBt (18 mg), NMM (14 p.and DMAP (16 mg) in low water THF (conc. of 2 mg cluster/mL). Following a brief activation period (10 minutes), five equivalents of an alcohol described in these examples was added to the reaction mixture and the solution was stirred at room temperature for 15 hours. The solvent was removed under vacuum and the 435 reacted MPC was collected on a frit where unreacted materials were removed by washing with 500 mL of acetonitrile followed by sonication/decanting with 50 mL
of acetonitrile (3X).
Example 7 440 2-naphthalene-ethanol (chromophore) The above procedure was carried out using 2-naphthalene-ethanol as the alcohol. The following data were obtained: NMR (in CD2C12): 8 (ppm) = 0.92 (br, 10 H), 1.3 (br, 69 H), 2.25 (br, 2 H), 3.4 (br, 1.1 H), 3.6 (br, 2 H}, 5.9 (br, 0.10 H), 6.5 (br, 0.11 H), 7.15 (br, 0:05 H), 7.4 (br, 0.17 H), 7.8 (br, 0.18 H) IR:
2851 (d'), 445 2922 (d-), 1739, 1653, 1118, 1070 crri'. The percent conversion to number coupled ratio was determined to be 85/11.5.
Example 8 Ferrocene-methanol (electroactive) 45o The above procedure was carried out using ferrocene-methanol as the alcohol. The following data were obtained: NMR (in CsDs): b (ppm) = 1.0 (br, WO 99/61911 PCT/US99/07$23 H), 1.5 (br, 226 H), 3.9 (br, 5 H), 4.2 (br, 1.3 H), 4.8 (br, 0.9 H) IR: 2851 (d+}, 2922 {d-), 1727, 1680, 1594, 1268, 124418: 2851 (d'), 2922 (d'), 1737, 1710, 1653, 1616 cm''. The percent conversion to number coupled ratio was 455 determined to be 50/5.
Example 9 a-D-glucose (sugar) The same procedure was employed except that a D-glucose was used 46o and a solvent 5:1 THFIDMF was employed to aid glucose solubility. The following data were obtained: NMR (in CD2C12): 8 (ppm) = 0.9 (br, 3 H), 1.3 (br, 17 H), 2.9 (br, 0.34 H) IR: 2850 (d+), 2920 (d'), 1815, 1733, 1647, 1612, 840, 781, 769, 740 crri'. The percent conversion to number coupled ratio was determined to be 35/5.

Example 10 Uridine (nucleotide) The same procedure was employed except uridine was used and a solvent 5:1 THF/DMF was employed to aid uridine solubility. The following data 47o were obtained: NMR (in CDZC12): 8 (ppm) = 0.9 (br, 3 H), 1.3 (br, 17 H), 2.9 (br, 0.85 H) IR: 2851 (d+), 2921 (d-), 1817, 1733, 1700, 1633, 1616, 1491, 1411, 843, 782, 764, 742 cm~'. The percent conversion to number coupled ratio was determined to be 60/8.
475 Exameles 11-12 Coupling of carboxylic acids to C12:C110H (a:b) In these examples, five equivalents (relative to moles of MPC alcohol) of a carboxylic acid was treated with five equivalents of BOP (60 mg), HOBt (18 mg), NMM (14~zL), and DMAP (16 mg) in low water THF (conc. of 2 mg cluster/mL).
48o Following a brief activation period (10 minutes), ca. 100 mg of the alcohol (C12:C110H (4:1)) was added and the solution was stirred at room temperature for 15 hours. The solvent was removed under vacuum and the reacted MPC
was collected on a frit where unreacted materials were removed by washing with 500 mL of acetonitrile followed by sonication/decanting with 50 mL
acetonitrile 485 (3X).
Example 11 10H-(phenothiazine-10)propionic acid (electroactive) The above procedure was carried out using 10H-(phenothiazine-4so 10)propionic acid as the acid. The following data were obtained: NMR (in CD2C12): s (ppm) - 0.9 (br, 17 H), 1.3 (br, 150 H), 2.75 (br, 0.2 H), 4.0 (br, 2 H), 4.1 (br, 2 H), 6.8 (br, 5.9 H), 7.1 (br, 5.9 H) IR: 2851 ,(d'), 2921 (d'), 1817, 1733, 1700, 1633, 1616, 1491, 1411, 843, 782, 764, 742 crri'. The electrochemistry of this MPC derivative is shown in Figure 3a. The percent conversion to number 495 coupled ratio was determined to be 65/7.4.
Example 12 Anthraquinone-2-carboxylic acid (electroactive; chromophore) 50o The above procedure was carried out using anthraquinone-2-carboxylic acid as the acid. The following data were obtained: NMR (in CD2Clz): 8 (ppm) _ 0.88 (br, 17 H), 1.3 (br, 119 H), 1.8 (br, 14 H), 3.55 (br, 1.8 H), 4.3 (br, 2 H), 7.8 (br, 1.8), 8.3 br, 3.4 H), 8.8 (br, 0.93 H) IR: 2851 (d~), 2922 (d-), 1727, 1680, 1594, 1268, 1244 cm-'. The percent conversion to number coupled ratio was 505 determined to be 75/7.5.
Example 13 Coupling of BOC-phenylalanine Five molar equivalents of BOC-phenylalanine (168 mg) were activated (10 5~o minutes) by treatment with five equivalents of BOP (280 mg), HOBt (87 mg), NMM (128 pL), and DMAP (77 mg) in THF (conc. of 2 mg cluster/mL). 200 mg of 3:1 C12:C1110H was added to the above and the solution was stirred at room temperature for 15 hours. The solvent was removed under vacuum and the reacted MPC was collected on a frit where unreacted materials were removed by 5~5 washing with 500 mL of acetonitrile followed by sonicationldecanting with 50 mL
acetonitrile (3X). The following data were obtained: NMR {in CgDe): 8 (ppm) _ 0.88 (br, 12.8 H), 1.35 (br, 48 H), 3.05 (br, 1.75 H), 3.55 (br, 2.2 H), 4.1 (br, 1.7 H), 4.5 (br, 0.3 H), 7.2 {d, 5 H).

Example 14 Deprotection of BOC-Phe-terminated MPC.
To a 30 ml solution of 1.0 g of BOC-Phe-terminated MPC (synthesized in Example 14) in CH2C12 was added 7.5 ml of trifluoroacetic acid. The reaction 525 was stirred at room temperature for 2 hours after which time the reaction mixture was diluted with 100 ml of distilled H20. The organic phase was separated, and the aqueous phase was further washed with 100 ml of CH2C12. The combined organic phases were washed with 2 x 100 ml of 10% NaHC03 and then removed in vacuo. The precipitate was then washed with copious quantities of acetonitrile 53o and was air dried. The following data were collected: NMR (in CD2C12): 8 (ppm) = 0.88 {br, 26 H), 1.35 (br, 192 H), 7.2 (d, 5 H).
Example 15 Coupling of BOC-alanine 535 BOC-alanine was coupled to the C-terminus of phenylalanine as described in Examples 2-8 (fve molar excess of reagents). The following data were obtained; NMR (in CsDs): b (ppm) = 0.85 (br, 13.6 H), 1.35 (br, 115 H), 3.05 (br, 2.6 H), 4.1 {br, 2.5 H), 4.7 (br, 0.6 H), 7.2 (d, 5 H).

Examale 16 Deprotection of BOC-Ala-Phe-terminated MPC
BOC-alanine was deprotected as described in Example 15. The following data were obtained: NMR (in CD2C12): 8 (ppm) = 0.85 (br, 16.8 H), 1.35 (br, H), 3.05 (br, 3.4 H), 4.1 (br, 1.9 H), 4.7 (br, 0.7 H), 7.2 (d, 5 H) 7.65 (br, 0.12 H).

Examale 17 Coupling of BOC-isoleucine BOC-isoleucine was coupled to the C-terminus of alanine as described in Examples 2-8 above (five molar excess of reagents). The following data were 550 obtained: NMR (in CsDs): b (ppm) = 0.85 (br, 18 H), 1.35 (br, 147 H), 3.05 (br, 2.6 H), 4.1 (br, 2.4 H), 4.7 (br, 0.02 H), 7.2 (d, 5 H). IR: 3063, 3029, 2848 (d'), 2917 (d'), 1738, 1718, 1687, 1644, 1513, 1497, 1164 cm''.
Examale 18 555 Deprotection of BOC-Ile-Ala-Phe-terminated MPC
BOC-isoleucine was deprotected as described in Example 15. The following data were obtained: NMR (in CD2C12): 8 (ppm) = 0.85 (br, 16.8 H), 1.35 (br, 156 H), 3.05 (br, 3.4 H), 4.1 (br, 1.9 H), 4.7 (br, 0.7 H), 7.2 (d, 5 H) 7.65 (br, 0.12 H).

Examale 19 Analysis of W-Carboxylic Acid-Alkanethiolate Functionalized MPCs using 12 Decomposition 5s5 Approximately 50 mg of the c~-carboxylic acid-alkanethiolate functionalized MPC was dissolved in dichloromethane and stirred with approximately 3 mg of iodine for one hour. Following disulfide formation, which was monitored by a change in solution color from dark brown to clear violet, the insoluble brown residue (actual identity of insoluble materials not identified) was 57o removed and the sample rotovapped to dryness. The NMR of the 12-WO 99/61911 ~ PCT/US99/07823 decomposed C12:C11COOH (4:1) (in CDC13) was: S (ppm) = 0.85 (t, 5.5 H), 1.25 (m, 35.4 H), 1.66 (m, 5.3 H), 2.35 (t,1 H), 2.65 (t,4 H).
Example 20 575 Electrochemical Measurement: Cyclic Voltammetry Cyclic voltammetry (seen in Figure 2) was performed with a BAS 1008 electrochemical analyzer sold by Bioanalytical Systems, Inc., located in West Lafayette, Indiana. A platinum 3 mm diameter working electrode was polished with 0.5 p.m diamond (Buehler) paste followed by rinsing with water, ethanol, and 5so acetone prior to each experiment. A Pt coil counter electrode and saturated calomel reference electrode resided in the same cell compartment as the working electrode. Solutions (2:1 toluene/acetonitrile as disclosed in Ingram et al., J.Am.Chem.Soc. 1996, 51, 1093} of the phenothiazine-MPC (0.8 mM in phenothiazine) and of phenothiazine monomer (1 mM) were degassed and then 585 bathed throughout with solvent-saturated N2.
Example 21 Electrochemical Measurement: Thin-layer coulometry Thin-layer coulometry (as seen in Figure 2b) was performed using a BAS
590 1008 electrochemical analyzer. A 4.3 mm diameter Pt working electrode was polished with 0.5 pm of diamond (Buehler) paste followed by rinsing with water, ethanol, and acetone and toluene prior to each experiment. A Pt wire counter electrode and Ag wire quasi-reference electrode (AgQRE) resided in a locally designed thin-layer cell as defined in Reilley, C.N., Pure Appl. Chem. 18 (1968) 595 137. A Mitutoyo digital micrometer (1-2", 0.00005" resolution) sold by Mitutoyo Corporation of Japan was fitted to the cell and used to define the thin-layer cell thickness, L. Charge-time measurements were performed for cell thicknesses of 2-30 pm, and Q values of zero-time intercepts extrapolated from the longer time plateaus (20-32 s) of each charge-time plot. The product of the number of 60o phenothiazines per cluster, 0, and of electrons per phenothiazine, n, is obtained from the slope of a Q versus L plot as shown in Figure 3b (Q/L = nFAC = 11.47 X
10-3 C/cm, C = 1.07x10'' mole/cm3).
In the drawings, specification, and examples there have been disclosed typical preferred embodiments of the invention and, although specific terms are soy employed, they are used in a generic and descriptive sense only and not for the purposes of limitation, the scope of the invention being set forth in the following claims.

Claims (33)

THAT WHICH IS CLAIMED:
1. A functionalized manometer-sized particle comprising:
a core comprising at least one metal or metal alloy; and a monolayer chemically bonded to said core, said monolayer containing at least one reactive substituent and wherein at least one reactive substituent is coupled to a functional material such that the monolayer is chemically modified.
2. The particle according to Claim 1, further including amide or ester linkages which couple at least one reactive substituent and the functional material together.
3. The particle according to Claim 1, wherein said at least one metal or metal alloy is selected from the group consisting of a semiconducting material, a metal oxide material, a Group VIIIA element, a Group IB element, a Group IIB
element, alloys thereof, and mixtures thereof.
4. The particle according to Claim 1, wherein said at least one metal or metal alloy is preferably selected from the group consisting of a Group VIIIA
element, a Group IB element, a Group IIB element, alloys thereof, and mixtures thereof.
5. The particle according to Claim 1, wherein said core has a diameter ranging from about 1 nm to about 999 nm.
6. The particle according to Claim 1, wherein said core has a diameter ranging from about 1 nm to about 100 nm.
7. The particle according to Claim 1, wherein said monolayer is formed during the formation of said core.
8. The particle according to Claim 1, wherein said monolayer comprises a material selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof.
9. The particle according to Claim 1, wherein said monolayer comprises substituents selected from the group consisting of straight-chained molecules, branched molecules, hyperbranched molecules, compounds containing functional groups, and mixtures thereof.
10. The particle according to Claim 1, wherein said chemically modified monolayer includes materials selected from the group consisting of nonreactive materials, partially reactive materials, and mixtures thereof.
11. The particle according to Claim 1, wherein said chemically modified monolayer is chemically bonded to said core by a bond selected from the group consisting of a core-element-sulfur bond, a core-element-oxygen bond, a core-element-nitrogen-bond, core-element-phosphorus, core-element-boron, and combinations thereof.
12. The particle according to Claim 1, wherein said monolayer comprises at least one alkanethiol compound or derivative thereof.
13. The particle according to Claim 1, wherein at least one reactive substituent comprises at least one compound having the general formula:
R n (EH)x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof; E is selected from the group consisting of S, O, NH2, NH, CO2, SO3OH, PO2(OH)2, BO(OH)2, and mixtures thereof; n is an integer ranging from 1 to 5; and x is an integer ranging from 1 to 10.
14. The particle according to Claim 1, wherein the at least one reactive substituent is selected from the group consisting of SH, OH, NH2, NH, CO2H, SO3OH, PO2(OH)2, BO(OH)2, and mixtures thereof.
15. The particle according to Claim 1, wherein the at least one reactive substituent is selected from the group consisting of OH, NH2, NH, CO2H, and mixtures thereof.
16. The particle according to Claim 1, wherein the at least one functional material coupled to said monolayer comprises functionality selected from the group consisting of SH, OH, NH2, NH, CO2H, SO3OH, PO2(OH)2, BO(OH)2, and mixtures thereof.
17. The particle according to Claim 1, wherein the at least one functional material coupled to said monolayer comprises functionality selected from the group consisting of OH, NH2, NH, CO2H, and mixtures thereof.
18. The particle according to Claim 1, wherein the functional material coupled to said monolayer is a catalyst.
19. The particle according to Claim 1, wherein the functional material coupled to said monolayer is a biomaterial.
20. The particle according to Claim 1, wherein the functional material coupled to said monolayer has a low-lying excited state which is capable of undergoing fluorescence or electron-transfer when excited.
21. The particle according to Claim 1, wherein the functional material coupled to said monolayer is electrochemically active.
22. A solvent containing a nanometer-sized particle as recited in Claim 1 dissolved therein.
23. A method of making a functionalized nanometer-sized particle, said method comprising:
providing a nanometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto core wherein said monolayer includes at feast one reactive substituent; and coupling the nanometer-sized particle with a functional material such the monolayer is chemically modified.
24. The method according to Claim 23, wherein at feast one reactive substituent comprises at least one compound having the general formula:
R n(EH)x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof; E is selected from the group consisting of S, O, NH2, NH, CO2, SO3OH, PO2(OH)2, BO(OH)2, and mixtures thereof; n is an integer ranging from 1 to 5; and x is an integer ranging from 1 to 10.
25. The method according to Claim 23, wherein the functional material comprises at least one compound having the general formula:
R n(EH)x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof; E is selected from the group consisting of S, O, NH2, NH, CO2, SO3OH, PO2(OH)2, BO(OH)2, and mixtures thereof; n is an integer ranging from 1 to 5; and x is an integer ranging from 1 to 10.
26. The particle according to Claim 25, wherein E is selected from the group consisting of O, NH2, NH, CO2; n is an integer ranging from 1 to 2; and x is an integer ranging from 1 to 3.
27. The method according to Claim 23, wherein the functional material is selected from the group consisting of spin labels, metal ligands, amino acids, chromophores, fluorophores, ionophores, molecules susceptible to functional group conversion, electroactive molecules, sugars, nucleotides, and mixtures thereof.
28. The method according to Claim 23, wherein said coupling step is carried out in the presence of a reagent selected from the group consisting of a phosphonium reagent, a facilitating reagent, and mixtures thereof.
29. The method according to Claim 28, wherein the facilitating reagent is selected from the group consisting of a base, a catalyst, and mixtures thereof.
30. The method according to Claim 29, wherein the base is a pyridine derivative.
31. The method according to Claim 23, wherein said coupling step is carried out in the presence of a component selected from the group consisting of benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate;
1-hydroxybenzotriazole; 4-methylmorpholine; 4-dimethylaminopyridine; and mixtures thereof.
32. A method of analyzing a nanometer-sized particle, said method comprising:
subjecting a manometer-sized particle as defined in Claim 1 to an analytical technique such that the composition of the functional materials of the monolayer on said particle is determined.
33. The method according to Claim 32, wherein the analytical technique is selected from the group consisting of NMR spectroscopy, electrochemical techniques, fluorescent emission spectropies, and infrared spectroscopy.
CA002329859A 1998-04-20 1999-04-09 Nanometer particles containing a reactive monolayer Abandoned CA2329859A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6286398A 1998-04-20 1998-04-20
US09/062,863 1998-04-20
PCT/US1999/007823 WO1999061911A2 (en) 1998-04-20 1999-04-09 Nanometer particles containing a reactive monolayer

Publications (1)

Publication Number Publication Date
CA2329859A1 true CA2329859A1 (en) 1999-12-02

Family

ID=22045338

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002329859A Abandoned CA2329859A1 (en) 1998-04-20 1999-04-09 Nanometer particles containing a reactive monolayer

Country Status (4)

Country Link
EP (1) EP1073902A2 (en)
AU (1) AU6016999A (en)
CA (1) CA2329859A1 (en)
WO (1) WO1999061911A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025414D0 (en) * 2000-10-16 2000-11-29 Consejo Superior Investigacion Nanoparticles
US6483125B1 (en) 2001-07-13 2002-11-19 North Carolina State University Single electron transistors in which the thickness of an insulating layer defines spacing between electrodes
US6653653B2 (en) 2001-07-13 2003-11-25 Quantum Logic Devices, Inc. Single-electron transistors and fabrication methods in which a projecting feature defines spacing between electrodes
GB0126236D0 (en) 2001-11-01 2002-01-02 Univ East Anglia Photosensitiser functionalised nanoparticles
US6673717B1 (en) 2002-06-26 2004-01-06 Quantum Logic Devices, Inc. Methods for fabricating nanopores for single-electron devices
GB0313259D0 (en) * 2003-06-09 2003-07-16 Consejo Superior Investigacion Magnetic nanoparticles
FR2859117B1 (en) * 2003-08-27 2006-02-03 Commissariat Energie Atomique USE OF NANOPARTICLES WITH A METAL HEART AND DOUBLE ORGANIC COATING AS CATALYSTS AND NANOPARTICLES USEFUL AS CATALYSTS
US9079765B2 (en) * 2004-10-01 2015-07-14 Midatech Ltd. Nanoparticles comprising antigens and adjuvants, and immunogenic structures
US7824466B2 (en) 2005-01-14 2010-11-02 Cabot Corporation Production of metal nanoparticles
CN1305977C (en) * 2005-03-04 2007-03-21 北京化工大学 Method for modifying the surface of nano inorganic particles by transfer method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2026409C (en) * 1989-09-29 2004-11-09 Ernest G. Schutt Method of producing a reagent containing a narrow distribution of colloidal particles of a selected size and the use thereof
GR1000686B (en) * 1989-11-16 1992-10-08 Ortho Diagnostic Systems Inc Method of producing a metal for reagent containing colloidal metal particles of a preselected size

Also Published As

Publication number Publication date
WO1999061911A3 (en) 2000-03-09
WO1999061911A2 (en) 1999-12-02
EP1073902A2 (en) 2001-02-07
AU6016999A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
Jia et al. Bioactivity-protected electrochemiluminescence biosensor using gold nanoclusters as the low-potential luminophor and Cu2S snowflake as co-reaction accelerator for procalcitonin analysis
Wang et al. Quantum dot-based near-infrared electrochemiluminescent immunosensor with gold nanoparticle-graphene nanosheet hybrids and silica nanospheres double-assisted signal amplification
Yuan et al. Sensitivity enhancement of SPR assay of progesterone based on mixed self-assembled monolayers using nanogold particles
Fox et al. Fluorescence and redox activity of probes anchored through an aminotrithiol to polycrystalline gold
EP2286234B1 (en) Novel au-ag core-shell composite useful for biosensor
US6872450B2 (en) Water-stable photoluminescent semiconductor nanocrystal complexes and method of making same
KR101088147B1 (en) Novel water-soluble nanocrystals and methods of preparing the same
CN104374764B (en) Analysis probe, preparation method and uses thereof
CN110438200A (en) A kind of biosensor for heavy metal lead ion detection based on dual signal amplification
Qi et al. Functionalization of single-walled carbon nanotubes with protein by click chemistry as sensing platform for sensitized electrochemical immunoassay
US20100004138A1 (en) Reagent for detecting biopolymer and method for detecting biopolymer
CA2329859A1 (en) Nanometer particles containing a reactive monolayer
CN104730056B (en) Method for carrying out SERS (Surface Enhanced Raman Scattering) detection by taking nano-grade Cu2-xS material as substrate
Xu et al. Ratiometric antifouling electrochemiluminescence biosensor based on bi-functional peptides and low toxic quantum dots
US7803568B2 (en) Carbodithioate ligands for nanotechnology and biosensing applications
Xu et al. Surface defect-involved and single-color electrochemiluminescence of gold nanoclusters for immunoassay
Fang et al. A self-enhanced renewable electrochemiluminescence biosensing platform for ultrasensitive detection of sialic acid
Taira et al. Electrode modification by long-chain, dialkyl disulfide reagent having terminal dinitrophenyl group and its application to impedimetric immunosensors
US7091517B2 (en) Patterned functionalized silicon surfaces
Gerami et al. Charge Transfer Surface-Enhanced Raman and Absorption Spectra of the Zwitterionic Form of Cysteine Adsorbed on M@ Au12 (M= Au, Ag, Pt, and Pd) Nanoclusters
US9157161B1 (en) Multifunctional thin film surface
Ahmadpor et al. A comparative study of different techniques for quantum dot nano-particles immobilization on glass surface for fabrication of solid phase fluorescence opto-sensors
JP2004022424A (en) Material for photoelectric transducing element containing host-guest complex
Wang et al. Polyviologen synthesis by self-assembly assisted grafting
WO2020232353A1 (en) Sensors and methods using electrochemiluminescence of metal nanoclusters

Legal Events

Date Code Title Description
FZDE Discontinued